Similarly, immunohistochemistry analysis in Crohn’s disease and ulcerative colitis patients showed the levels of activation markers like CD83 and CD86 expressed on DCs, primarily mDCs, were significantly higher in inflamed mucosa from patients compared with non-inflamed mucosa and healthy controls42,43. This evidence concerns the gene CD86 and Crohn disease.